Jump to main content
Jump to site search

Issue 6, 2014
Previous Article Next Article

Designing nanoparticle carriers for enhanced drug efficacy in photodynamic therapy

Author affiliations

Abstract

Although nanoparticles (NPs) have been proposed as carriers for photosensitizers (PS) in photodynamic therapy (PDT), how the design parameters of nanocarriers affect the final drug efficacy remains unclear. By designing SiO2-PS NPs with specific features (such as enabling easy release of PS from the nanocarriers, or introducing plasmonic Au NPs in the vicinity of the PS), and comparing the respective efficacy of PS to that of the conventional dense SiO2-PS NPs (PS were tightly confined into the silica matrix), we identified that both PS trapping-in/releasing from the silica nanocarriers and the Au plasmonic effect were responsible for the PS efficacy variation. The mechanistic study also disclosed that the different NP configurations would affect the cellular death pathway. These findings provide a general guideline for the design of NP-based PDT applications.

Graphical abstract: Designing nanoparticle carriers for enhanced drug efficacy in photodynamic therapy

Back to tab navigation

Supplementary files

Article information


Submitted
21 Jan 2014
Accepted
17 Feb 2014
First published
19 Mar 2014

Biomater. Sci., 2014,2, 827-832
Article type
Paper
Author version available

Designing nanoparticle carriers for enhanced drug efficacy in photodynamic therapy

Z. Chu, S. Zhang, C. Yin, G. Lin and Q. Li, Biomater. Sci., 2014, 2, 827
DOI: 10.1039/C4BM00024B

Social activity

Search articles by author

Spotlight

Advertisements